Stuart Raetzman Archives - CDR – Chain Drug Review

Harrison promoted to president at Galderma Labs

January 12, 2016 by Chain Drug Review Galderma Laboratories, Galderma Pharma, Miles Harrison, Stuart Raetzman Supplier News

FORT WORTH, Texas — Miles Harrison has been promoted to president and general manager of Galderma Laboratories L.P. Galderma said Monday that Harrison will lead the U.S. and Canada teams. He joined Galderma U.S. in 2014 as the vice president and GM of the company’s Self-Medication Business Unit, which includes its flagship brand Cetaphil. Before

Galderma makes exec moves in business realignment

March 12, 2015 by Chain Drug Review and Chain Drug Review Galderma, Humberto Antunes, Nestle Skin Health, Stuart Raetzman, Todd Zavodnick Supplier News

FORT WORTH, Texas — Galderma has made a series of executive appointments and announced a realignment of its North America business. The dermatology and skin care company said Thursday that Stuart Raetzman has been named as global chief executive officer of Galderma Pharma S.A. He reports to Humberto Antunes, chairman of Galderma Pharma S.A. and